PIK3CA c.2693C>T ;(p.T898I)

Variant ID: 3-178947818-C-T

NM_006218.2(PIK3CA):c.2693C>T;(p.T898I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: PIK3CA: 2693C>T; T898I
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.

British Journal Of Cancer
Toi, M M; Iwata, H H; Fujiwara, Y Y; Ito, Y Y; Nakamura, S S; Tokuda, Y Y; Taguchi, T T; Rai, Y Y; Aogi, K K; Arai, T T; Watanabe, J J; Wakamatsu, T T; Katsura, K K; Ellis, C E CE; Gagnon, R C RC; Allen, K E KE; Sasaki, Y Y; Takashima, S S
Publication Date: 2009-11-17

Variant appearance in text: PIK3CA: T898I
PubMed Link: 19844234
Variant Present in the following documents:
  • Main text
  • 6605343a.pdf
View BVdb publication page